Web Exclusives

Thumbnail image for NIHR welcomes Life Sciences Sector Deal 2

NIHR welcomes Life Sciences Sector Deal 2

Professor Chris Whitty, chief scientific adviser for the Department of Health and Social Care (DHSC), on the role of the NIHR and the promise of the government's second sector deal for the life sciences industry.

6th December 2018

Thumbnail image for Adapting to the challenge

Adapting to the challenge

Mark Toms, chief scientific officer at Novartis Pharmaceuticals UK, looks at how to address the challenges of recruiting for Alzheimer’s prevention studies.

6th December 2018

Thumbnail image for Orphan drug development and the urgent need for a new approach

Orphan drug development and the urgent need for a new approach

There are around 7,000 rare diseases for which there currently exists no authorised or satisfactory method of treatment, highlighting a vast area of unmet need, and yet the clinical development of orphan drugs is still fraught with many practical challenges.

5th December 2018

Thumbnail image for A blow for innovation?

A blow for innovation?

Second medical use patents have taken a blow with the Supreme Court’s recent ruling in Warner-Lambert v Mylan and Actavis.

21st November 2018

Thumbnail image for A new age of virtual trials?

A new age of virtual trials?

We spoke to Medidata’s General Manager and Senior Vice President EMEA Christian Hebenstreit at the New York NEXT conference to find out how virtual trials could change R&D

12th November 2018

Previous  --   1 2 3 4 5 6 7   --  Next

Download our apps

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Download